| A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects (NCT02096666) | Amgen | 2014-04-15 |
| Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer (NCT02085031) | Nanfang Hospital, Southern Medical University | 2014-04-01 |
| Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer (NCT02305043) | University of Leipzig | 2014-03-01 |
| Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors (NCT02016534) | Amgen | 2014-02-01 |
| A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma (NCT02301481) | Chinese Academy of Medical Sciences | 2014-01-01 |
| A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer (NCT02296658) | Chinese Academy of Medical Sciences | 2014-01-01 |
| Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer (NCT02385617) | St. James's Hospital, Ireland | 2014-01-01 |
| Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer (NCT01928290) | Washington University School of Medicine | 2013-11-08 |
| Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer (NCT02004769) | Sun Yat-sen University | 2013-11-01 |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma (NCT01950572) | National Cancer Institute (NCI) | 2013-09-09 |
| A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer (NCT01967875) | China Medical University, China | 2013-07-01 |
| Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC (NCT03061058) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2013-04-01 |
| Botulinum Toxin for Stomach Cancer Treatment (NCT01822210) | St. Olavs Hospital | 2013-01-01 |
| Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma (NCT01821196) | St. Olavs Hospital | 2012-12-01 |
| Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) (NCT01609309) | Nanfang Hospital, Southern Medical University | 2012-09-01 |
| Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. (NCT01649271) | Boehringer Ingelheim | 2012-07-23 |
| Compliance to ERAS After Gastric Surgery (NCT01653496) | Chonnam National University Hospital | 2012-07-01 |
| Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy (NCT01653171) | Pontificia Universidad Catolica de Chile | 2012-07-01 |
| A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients (NCT01576380) | Novartis Pharmaceuticals | 2012-06-01 |
| Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers (NCT01911832) | West China Hospital | 2012-03-01 |
| Omentectomy in Radical Gastrectomy for Gastric Cancer Trial (NCT02050659) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-03-01 |
| A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 (NCT01614522) | ASLAN Pharmaceuticals | 2012-03-01 |
| Acetic Acid Chromoendoscopy to Judge Gastric Intestinal Metaplasia (NCT01499576) | Konyang University Hospital | 2011-11-01 |
| The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients (NCT01421680) | Seoul National University Hospital | 2011-08-01 |
| Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy (NCT01384253) | Orano Med LLC | 2011-07-01 |
| S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma (NCT01364376) | Zhejiang University | 2011-06-01 |
| The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer (NCT01531452) | Chinese Academy of Medical Sciences | 2011-06-01 |
| Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer (NCT01830270) | Centre Hospitalier Universitaire de Besancon | 2011-05-01 |
| Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer (NCT01943253) | Shanghai Zhongshan Hospital | 2011-05-01 |
| ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction (NCT01234324) | AIO-Studien-gGmbH | 2010-10-01 |
| Helicobacter Pylori Eradication to Prevent Gastric Cancer (NCT01133951) | Jie-Jun Wang | 2010-06-01 |
| Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT) (NCT02686424) | Seoul National University Hospital | 2010-03-01 |
| Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer (NCT01617876) | Peking Union Medical College Hospital | 2010-03-01 |
| Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer (NCT04439812) | Hospital Universitario Ramon y Cajal | 2010-01-01 |
| Gastric Cancer Liver Metastasis Cohort of China (NCT04574245) | Chinese PLA General Hospital | 2010-01-01 |
| a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Lesions (NCT01508520) | Xiaobo Li | 2009-12-01 |
| Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnife (NCT01185483) | Odense University Hospital | 2009-11-01 |
| Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer (NCT00983801) | R-Pharm | 2009-11-01 |
| A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas (NCT00909402) | Bristol-Myers Squibb | 2009-11-01 |
| Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma (NCT02370849) | Chinese Academy of Medical Sciences | 2009-10-01 |
| Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer (NCT00842244) | Pfizer | 2009-04-01 |
| Taxotere New Indication - Gastric Cancer Treatment Registration Trial (NCT00811447) | Sanofi | 2008-11-01 |
| Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy (NCT00851305) | Shandong University | 2008-08-01 |
| Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer (NCT00555672) | Pfizer | 2008-08-01 |
| Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery (NCT04002128) | Osijek University Hospital | 2008-01-01 |
| Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer (NCT00591045) | Peking University | 2008-01-01 |
| Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00813072) | PharmaEngine | 2007-11-01 |
| Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery (NCT00560846) | Dan Azagury | 2007-11-01 |
| Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer (NCT00553696) | Pfizer | 2007-11-01 |
| Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors (NCT00515216) | Vanderbilt University | 2007-08-01 |
| Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer (NCT00525005) | Hallym University Medical Center | 2007-08-01 |
| Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer (NCT00511446) | Martin-Luther-Universität Halle-Wittenberg | 2007-08-01 |
| A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer (NCT00512681) | National Cancer Center, Korea | 2007-07-01 |
| Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma (NCT00515190) | National Cancer Center, Korea | 2007-07-01 |
| S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer (NCT00580359) | National Cancer Center, Korea | 2007-05-01 |
| huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas (NCT00620607) | ImmunoGen, Inc. | 2007-05-01 |
| Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer (NCT00420394) | Soroka University Medical Center | 2007-04-01 |
| Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis (NCT00454519) | Wuhan University | 2007-03-01 |
| Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas (NCT00419627) | Hillel Yaffe Medical Center | 2007-02-01 |
| Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma (NCT00447330) | Duke University | 2007-02-01 |
| Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma (NCT00390416) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Docetaxel and Oxaliplatin in Gastric Cancer (NCT00382720) | Sanofi | 2006-09-01 |
| Docetaxel and Epirubicin in Advanced Gastric Cancer (NCT00375999) | Yonsei University | 2006-09-01 |
| Docetaxel in Locally Advanced Gastric Adenocarcinoma (NCT00343239) | Sanofi | 2006-06-01 |
| Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer (NCT00669370) | University of Turku | 2006-06-01 |
| Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer (NCT00411229) | Sanofi | 2006-06-01 |
| Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer (NCT00384878) | Far Eastern Memorial Hospital | 2006-06-01 |
| Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer (NCT00587145) | National Cancer Center, Korea | 2006-05-01 |
| OLGA and OLGIM Stage System for Gastric Cancer (NCT03380052) | Seoul National University Bundang Hospital | 2006-02-01 |
| An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy (NCT00226811) | Pfizer | 2006-01-01 |
| Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction (NCT00374985) | Johannes Gutenberg University Mainz | 2005-10-01 |
| Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding (NCT00539877) | Samsung Medical Center | 2004-10-01 |
| A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma (NCT00980382) | National Cancer Center, Korea | 2004-09-01 |
| Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy (NCT00087503) | Pfizer | 2004-04-01 |
| Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway (NCT00498134) | Hospital Authority, Hong Kong | 2004-03-01 |
| Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer (NCT00054873) | Chiron Corporation | 2003-11-01 |
| Oxaliplatin in Gastric Cancer (NCT00263354) | Sanofi | 2003-10-01 |
| A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer (NCT00611507) | Sanofi | 2002-11-01 |
| Study of Adjuvant Radiochemotherapy for Gastric Cancer (NCT00188266) | University Health Network, Toronto | 2002-08-01 |
| Institut Paoli Calmettes Cardia Cancer Database (NCT02869477) | Institut Paoli-Calmettes | 2002-01-01 |
| Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery (NCT00036400) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-12-01 |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver (NCT00041808) | FeRx | 2001-07-01 |
| Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample (NCT00568438) | Stanford University | 2000-10-01 |
| Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer (NCT00042510) | Cancer Advances Inc. | 2000-08-01 |
| A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab (NCT00001805) | National Cancer Institute (NCI) | 1999-03-01 |
| Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis (NCT00001332) | National Cancer Institute (NCI) | 1992-12-01 |
| An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer (NCT00270543) | Far Eastern Memorial Hospital | |